This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 1120186
Submitted by lobbyist on: March 17, 2020 04:42:13 PM
Accepted by Registrar on: March 18, 2020 03:16:23 PM
Designated Filer Information
| Macher, Christian |
| 385 Boul Bouchard | |
|
Dorval, QC, H9S 1A9
|
514-631-6775 |
| Canada |
Organization Information
| Novartis Pharmaceuticals Canada Inc. |
| Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative medicines and procedures to improve the health and well-being of Canadians. Novartis is a leading investor in pharmaceutical research and development worldwide and in Canada. Novartis Pharmaceuticals Canada Inc. employs more than 600 people and has been named multiple times as one of the "50 Best Employers in Canada". For further information, please visit www.novartis.ca. |
| 22093 46B Avenue | |
|
Langley, BC, V2Z 1A9
|
604-218-9838 |
| Canada |
Relevant Affiliates
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| March 17, 2020 | |
| September 17, 2020 |
Organization's In-House Lobbyists
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Discussions with elected representatives and BC government officials/organizations regarding reimbursement of Novartis' innovative treatments by the BC government for citizens that require access to these treatments.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 17, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Discussions with elected representatives and BC government officials/organizations regarding reimbursement of Novartis' innovative treatments by the BC government for citizens that require access to these treatments.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 17, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Discussions with elected representatives and BC government officials/organizations regarding reimbursement of Novartis' innovative treatments by the BC government for citizens that require access to these treatments.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 17, 2020 |
|
|||
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
Discussions with elected representatives and BC government officials/organizations regarding reimbursement of Novartis' innovative treatments by the BC government for citizens that require access to these treatments.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 17, 2020 |